Free Trial

Merck KGaA (ETR:MRK) Shares Up 0.4% - Here's Why

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA's shares increased by 0.4%, trading at €106.60 ($125.41) on Monday, up from a previous close of €106.20.
  • The company has a market capitalization of $47.78 billion and a price-to-earnings ratio of 17.63.
  • Merck KGaA operates in the Life Science, Healthcare, and Electronics sectors, providing tools and chemicals for various scientific and industrial applications.
  • Interested in Merck KGaA? Here are five stocks we like better.

Shares of Merck KGaA (ETR:MRK - Get Free Report) shot up 0.4% on Monday . The company traded as high as €107.05 ($125.94) and last traded at €106.60 ($125.41). 216,332 shares were traded during mid-day trading, The stock had previously closed at €106.20 ($124.94).

Merck KGaA Stock Performance

The stock has a market cap of $47.78 billion, a price-to-earnings ratio of 17.63, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71. The company has a 50-day simple moving average of €109.25 and a two-hundred day simple moving average of €114.97.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.